These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16291522)

  • 21. [Study on distribution of endemic arsenism in China].
    Jin Y; Liang C; He G; Cao J
    Wei Sheng Yan Jiu; 2003 Nov; 32(6):519-40. PubMed ID: 14963897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicokinetics/toxicodynamics of arsenic for farmed juvenile milkfish Chanos chanos and human consumption risk in BFD-endemic area of Taiwan.
    Chou BY; Liao CM; Lin MC; Cheng HH
    Environ Int; 2006 May; 32(4):545-53. PubMed ID: 16513169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
    Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arsenicosis: review of recent advances.
    Pimparkar BD; Bhave A
    J Assoc Physicians India; 2010 Oct; 58():617-24, 629. PubMed ID: 21510113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk characterization and exposure assessment in arseniasis-endemic areas of Taiwan.
    Ling MP; Liao CM
    Environ Int; 2007 Jan; 33(1):98-107. PubMed ID: 17014909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of urinary trace elements (arsenic, copper, cadmium, manganese, lead, zinc, selenium) in patients with Blackfoot disease.
    Tsai JL; Horng PH; Hwang TJ; Hsu JW; Horng CJ
    Arch Environ Health; 2004 Dec; 59(12):686-92. PubMed ID: 16789478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-endothelial cell IgG from patients with chronic arsenic poisoning induces endothelial proliferation and VEGF-dependent angiogenesis.
    Hong CH; Lee CH; Chang LW; Chiou MH; Hsieh MC; Kao YH; Yu HS
    Microvasc Res; 2008 Nov; 76(3):194-201. PubMed ID: 18671988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hepatitis B surface antigen carrier status among residents in the endemic area of chronic arsenicism in Taiwan.
    Lu JN; Chen CJ
    Anticancer Res; 1991; 11(1):229-33. PubMed ID: 2018356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan.
    Chiou HY; Hsueh YM; Liaw KF; Horng SF; Chiang MH; Pu YS; Lin JS; Huang CH; Chen CJ
    Cancer Res; 1995 Mar; 55(6):1296-300. PubMed ID: 7882325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arsenic cancer risk posed to human health from tilapia consumption in Taiwan.
    Liao CM; Shen HH; Lin TL; Chen SC; Chen CL; Hsu LI; Chen CJ
    Ecotoxicol Environ Saf; 2008 May; 70(1):27-37. PubMed ID: 18068227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan.
    Tan LB; Chen KT; Guo HR
    BJU Int; 2008 Jul; 102(1):48-54. PubMed ID: 18445081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease.
    Chen CJ; Wu MM; Lee SS; Wang JD; Cheng SH; Wu HY
    Arteriosclerosis; 1988; 8(5):452-60. PubMed ID: 3190552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal peripheral microcirculation in seemingly normal subjects living in blackfoot-disease-hyperendemic villages in Taiwan.
    Tseng CH; Chong CK; Chen CJ; Lin BJ; Tai TY
    Int J Microcirc Clin Exp; 1995; 15(1):21-7. PubMed ID: 7558622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health hazards and mitigation of chronic poisoning from arsenic in drinking water: Taiwan experiences.
    Chen CJ
    Rev Environ Health; 2014; 29(1-2):13-9. PubMed ID: 24552958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral vascular diseases resulting from chronic arsenical poisoning.
    Yu HS; Lee CH; Chen GS
    J Dermatol; 2002 Mar; 29(3):123-30. PubMed ID: 11990246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview on chronic arsenism via drinking water in PR China.
    Xia Y; Liu J
    Toxicology; 2004 May; 198(1-3):25-9. PubMed ID: 15138026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic contamination and arsenicosis in China.
    Sun G
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):268-71. PubMed ID: 15276405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bladder cancer and arsenic exposure: differences in the two populations enrolled in a study in southwest Taiwan.
    Lamm SH; Byrd DM; Kruse MB; Feinleib M; Lai SH
    Biomed Environ Sci; 2003 Dec; 16(4):355-68. PubMed ID: 15011967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effect of polymorphisms of paraoxonase gene cluster and arsenic exposure on electrocardiogram abnormality.
    Liao YT; Li WF; Chen CJ; Prineas RJ; Chen WJ; Zhang ZM; Sun CW; Wang SL
    Toxicol Appl Pharmacol; 2009 Sep; 239(2):178-83. PubMed ID: 19152805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in arsenic intake from water has different impacts on lung cancer and bladder cancer in an arseniasis endemic area in Taiwan.
    Su CC; Lu JL; Tsai KY; Lian IeB
    Cancer Causes Control; 2011 Jan; 22(1):101-8. PubMed ID: 21052815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.